Spongiotic dermatitis describes skin inflammation that causes swelling, redness, and itching. It's most often associated with ...

Dupixent (dupilumab) achieved a five-fold greater sustained remission rate at 36 weeks than placebo in the study – 20% versus 4% – meaning that the skin lesions had been resolved, with no ...

In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.

A research team has developed a diagnostic system that uses artificial intelligence (AI) to accurately identify the type of ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...

Your brain and skin are interconnected—and when a disorder affects both, treatment must involve a multidisciplinary approach.

FDA grants accelerated approval to Regeneron's Lynozyfic for relapsed multiple myeloma after strong results in a Phase 1/2 trial.

Rare, deadly, and often missed, some skin cancers develop in areas that rarely see the sun. Scientists are still learning about them, but here's what we know.

RA primarily affects the joints, but it can also cause symptoms in other areas of the body, such as the skin. Learn how RA ...

A research team led by Haruyo Yamamoto, Chisa Nakashima, and Atsushi Otsuka from Department of Dermatology, Kindai University Faculty of Medicine, in collaboration with the Faculty of Engineering at ...

An artificial intelligence-powered tool for triaging patients with suspicious skin lesions, developed by Skin Analytics, will be used by the NHS to reduce waiting times. DERM (Deep Ensemble for ...

Such cases are common in the growing population of older adults, where the incidence of nonmelanoma skin cancer is high and factors such ... effectively clearing the lesion and avoiding potential ...